Waltham, MA, United States of America

Kathleen McCarthy


 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Waltham, MA (US) (2021 - 2022)
  • Somerville, MA (US) (2022 - 2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations by Kathleen McCarthy

Introduction

Kathleen McCarthy is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of mRNA splicing. With a total of nine patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents are "Methods and compositions for modulating splicing," which describes small molecule splicing modulator compounds that can modulate the splicing of mRNA, such as pre-mRNA encoded by genes. This innovation includes methods for using these compounds to treat diseases and conditions. Another notable patent is "Compounds for the treatment of cancer," which details splice modifying compounds that affect the splicing of mRNA expressed from the FOXM1 gene, along with compositions and methods utilizing these compounds.

Career Highlights

Kathleen McCarthy is currently associated with Skyhawk Therapeutics, Inc., where she continues to advance her research and innovations. Her work is at the forefront of developing new therapeutic strategies that leverage the modulation of mRNA splicing.

Collaborations

She collaborates with notable colleagues, including Michael Luzzio and William Haney, to further enhance the impact of her research in the field.

Conclusion

Kathleen McCarthy's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work promises to pave the way for new treatments and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…